Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endophthalmitis Post Intravitreal Injections Comparison EPIIC Trial: Pars Plana Vitrectomy Versus Tap and Inject

NCT04035369 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04035369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04035369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endophthalmitis Post Intravitreal Injections Comparison EPIIC Trial: Pars Plana Vitrectomy Versus Tap and Inject
Lead sponsor
Unity Health Toronto
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2020
Completion date
July 31, 2024
Enrollment
310 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endophthalmitis